lilly glp 1 Eli to seek approval of new GLP-1 weight-loss drug this year Lilly is selling $12.9 billion
Description
Fatty infiltration of the pancreas promotes impaired pancreatic -cell function and gradual hyperglycemia, which will further enhance de novo hepatic lipogenesis and promote higher NEFAs levels to the circulation (the twin cycle hypothesis) [18]
Chen, W
This hormone does several important things simultaneously
Lancet 392 , 21802193 (2018) D
(22 December 2025, data last accessed)
